Author:
Tasoudis Panagiotis,Loufopoulos Georgios,Manaki Vasiliki,Doerr Mitchell,Agala Chris B.,Long Jason M.,Haithcock Benjamin E.
Reference46 articles.
1. NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer. Version 1.2023, (n.d.). https://www.nccn.org/guidelines/recently-published-guidelines (accessed September 12, 2022).
2. Lung Cancer Study Group, Randomized Trial of Lobectomy Versus Limited Resection for T1 N0 Non-Small Cell Lung Cancer;Ginsberg;Annals of Thoracic Surgery,1995
3. Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer;Altorki;New England Journal of Medicine,2023
4. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503), Lancet;Altorki;Respir Med,2018
5. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial;Saji;Lancet,2022